Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 4: Ulcerative Colitis
Submit an article Journal homepage
4,345
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Rationale for IL-36 receptor antibodies in ulcerative colitis

Clemens NeufertFirst Department of Medicine, Friedrich-Alexander-University Erlangen-Nuernberg, Erlangen, GermanyCorrespondence[email protected]
View further author information
,
Markus F. NeurathFirst Department of Medicine, Friedrich-Alexander-University Erlangen-Nuernberg, Erlangen, GermanyView further author information
&
Raja AtreyaFirst Department of Medicine, Friedrich-Alexander-University Erlangen-Nuernberg, Erlangen, GermanyView further author information
Pages 339-342 | Received 13 Sep 2019, Accepted 18 Nov 2019, Published online: 27 Nov 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marc Ferrante, Peter M Irving, Christian P Selinger, Geert D’Haens, Tanja Kuehbacher, Ursula Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus & Brian G. Feagan$suffix/text()$suffix/text(). (2023) Safety and tolerability of spesolimab in patients with ulcerative colitis. Expert Opinion on Drug Safety 22:2, pages 141-152.
Read now

Articles from other publishers (12)

Masaaki Higashiyama & Ryota Hokari. (2023) New and Emerging Treatments for Inflammatory Bowel Disease. Digestion 104:1, pages 74-81.
Crossref
Sophie Vieujean, Ferdinando D’Amico, Patrick Netter, Silvio Danese & Laurent Peyrin‐Biroulet. (2022) Landscape of new drugs and targets in inflammatory bowel disease. United European Gastroenterology Journal 10:10, pages 1129-1166.
Crossref
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet & Silvio Danese. (2021) Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nature Reviews Gastroenterology & Hepatology 19:3, pages 169-184.
Crossref
Aderson Omar Mourão Cintra Damião & Natália Sousa Freitas Queiroz. (2022) Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough. Clinics in Colon and Rectal Surgery 35:01, pages 032-043.
Crossref
Semra Eroglu & Elcin Kal Cakmakliogullari. (2021) Decreased serum profile of the interleukin-36α in polycystic ovary syndrome. Taiwanese Journal of Obstetrics and Gynecology 60:6, pages 1018-1022.
Crossref
Wen-jian Chen, Xiao Yu, Xin-Rong Yuan, Bang-jie Chen, Na Cai, Shuo Zeng, Yuan-song Sun & Hai-wen Li. (2021) The Role of IL-36 in the Pathophysiological Processes of Autoimmune Diseases. Frontiers in Pharmacology 12.
Crossref
Sanjukta Majumder, Pratibha Singh, Rudrarpan Chatterjee, Sarit Sekhar Pattnaik & Amita Aggarwal. (2021) Elevated urinary IL-36γ in patients with active lupus nephritis and response to treatment. Lupus 30:6, pages 921-925.
Crossref
Yan Li, Sisi Chen, Tingqi Zhao & Mingcai Li. (2020) Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation. Journal of Clinical Laboratory Analysis 35:2.
Crossref
Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese & Gionata Fiorino. (2020) New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?. Current Opinion in Pharmacology 55, pages 141-150.
Crossref
Bergithe E. Oftedal & Anette S. B. Wolff. (2020) New era of therapy for endocrine autoimmune disorders. Scandinavian Journal of Immunology 92:5.
Crossref
Elaina Melton & Hongyu Qiu. (2020) Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis. International Journal of Molecular Sciences 21:18, pages 6458.
Crossref
Bo Yang, Ge Zhang, Michael Elias, Yijun Zhu & Jie Wang. (2020) The role of cytokine and immune responses in intestinal fibrosis. Journal of Digestive Diseases 21:6, pages 308-314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.